Taming Albuminuria to prevent cardiovascular and renal outcomes

Taming Albuminuria to prevent cardiovascular and renal outcomes

CardiologyEndocrinologyInternal MedicineFamily MedicineGeneral Practice
A badge with ribbon in color black CPD Unit: 1 Point | An analog clock in color black 27 Minutes | A black calendar with white triangle in center that has a black exclamation point in the middle 18 Nov 2025 

Overview

About this course

Albuminuria serves as a vital early marker of cardiovascular and kidney disease in diabetic patients, reflecting underlying vascular damage and increased health risks.

This module covers the significance of albuminuria in risk assessment and the protective role of Irbesartan in managing its progression, with a focus on kidney preservation. Participants will also learn to implement antihypertensive therapies that offer cardiovascular protection, gaining practical strategies to enhance patient outcomes in cardio-renal health.

Learning outcomes:

  1. Understand the role of albuminuria in detecting cardiovascular disease in diabetic patients
  2. Understand the role of Irbesartan in preventing the progression of albuminuria and its role in kidney protection.
  3. Apply in practice appropriate antihypertensive therapy providing cardiovascular protection

Topics covered

Hypertension
Chronic Kidney Disease
Albuminuria Management
RAAS Inhibitors Treatment guidelines


Speaker

Elmer Jasper B. Llanes, MD, FPCP, FPCC
Nuclear Cardiologist
Vice President, Philippine Lipid and Atherosclerosis Society
Past Chair, Council of Preventive Cardiology, Philippine Heart Association
Clinical Associate Professor, University of the Philippines - Philippine General Hospital

1 CPD Point Available

  • Score at least 80% on the quiz.
  • A certificate can be downloaded upon successful completion of the quiz. Please use the information on the certificate to claim your CPD points.
Something went wrong.